[General principles and first clinical trials of therapeutic vaccines against cancer].


In this brief review we describe the general principles of the antigenicity of human tumor cells, which can be recognized by T lymphocytes and particularly by cytolytic T lymphocytes. This antigenicity of tumor cells lead to the development of therapeutic anticancer vaccines that should induce tumor regressions or prevent the development of metastases in… (More)
DOI: 10.1684/bdc.2008.0588


  • Presentations referencing similar topics